The company expects the approval will add $200 million to annualized gross margin in the United States and Japan by the end of 2012.
The early approval might allow the company to record a pretax charge of $40 million during the fourth quarter of this year.
Related Articles on Medical Device Approvals:
FDA Clears Aptus Endosystems EndoStapling System
FDA Approves Carestream’s Vue Motion Medical Image Viewer
FDA Approval for Edwards’ Sapien Device is a First for U.S. Market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.